Balázs Margit

1.

Várvölgyi, T., Janka, E. A., Szász, I., Koroknai, V., Toka-Farkas, T., Szabó, I. L., Ványai, B., Szegedi, A., Emri, G., Balázs, M.: Combining Biomarkers for the Diagnosis of Metastatic Melanoma.
J Clin Med. 13 (1), 1-13, (article identifier: 174), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous) (2023)

2.

Imre, L., Nánási, P. P. i., Benhamza, I., Enyedi, K. N., Mocsár, G., Bosire, R., Hegedűs, É., Niaki, E. F., Csóti, Á., Darula, Z., Csősz, É., Póliska, S., Scholtz, B., Mező, G., Bacsó, Z., Timmers, H. T. M., Kusakabe, M., Balázs, M., Vámosi, G., Ausio, J., Cheung, P., Tóth, K., Tremethick, D., Harata, M., Szabó, G.: Epigenetic modulation via the C-terminal tail of H2A.Z.
Nat Comms. 15 (1), 1-21, (article identifier: 9171), 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)

D1 Chemistry (miscellaneous) (2023)

D1 Physics and Astronomy (miscellaneous) (2023)

3.

Koroknai, V., Szász, I., Jámbor, K., Balázs, M.: Expression pattern of osteopontin isoforms in malignant melanoma cell lines.
CTS-Clin. Transl. Sci. 17 (1), 1-10, (article identifier: 13694), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)

Q1 Medicine (miscellaneous) (2023)

Q2 Neuroscience (miscellaneous) (2023)

D1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (2023)

4.

Szász, I., Koroknai, V., Várvölgyi, T., Pál, L., Szűcs, S., Pikó, P., Emri, G., Janka, E. A., Szabó, I. L., Ádány, R., Balázs, M.: Identification of Plasma Lipid Alterations Associated with Melanoma Metastasis.
Int. J. Mol. Sci. 25 (8), 1-15, (article identifier: 4251), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis (2023)

Q1 Computer Science Applications (2023)

D1 Inorganic Chemistry (2023)

Q1 Medicine (miscellaneous) (2023)

Q2 Molecular Biology (2023)

D1 Organic Chemistry (2023)

Q1 Physical and Theoretical Chemistry (2023)

D1 Spectroscopy (2023)

5.

Koroknai, V., Szász, I., Balázs, M.: Gene Expression Changes in Cytokine and Chemokine Receptors in Association with Melanoma Liver Metastasis.
Int. J. Mol. Sci. 24 (10), 1-13, (article identifier: 8901), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

6.

Szász, I., Kiss, T., Mokánszki, A., Koroknai, V., Deák, J., Patel, V., Jámbor, K., Ádány, R., Balázs, M.: Identification of liquid biopsy-based mutations in colorectal cancer by targeted sequencing assays.
Mol. Cell. Probes. 67, 1-8, (article identifier: 101888), 2023.

doi DEA Scopus

Journal metrics:

Q3 Cell Biology

Q3 Molecular Biology

7.

Burai, S., Kovács, R., Molnár, T., Tóth, M., Szendi-Szatmári, T., Jenei, V., Bíró-Debreceni, Z., Brisco, S., Balázs, M., Bácsi, A., Koncz, G., Türk-Mázló, A.: Comprehensive analysis of different tumor cell-line produced soluble mediators on the differentiation and functional properties of monocyte-derived dendritic cells.
PLoS One. 17 (10), 1-23, 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Multidisciplinary

8.

Koroknai, V., Szász, I., Jámbor, K., Balázs, M.: Cytokine and Chemokine Receptor Patterns of Human Malignant Melanoma Cell Lines.
Int. J. Mol. Sci. 23 (5), 1-10, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

9.

Jámbor, K., Koroknai, V., Kiss, T., Szász, I., Pikó, P., Balázs, M.: Gene Expression Patterns of Osteopontin Isoforms and Integrins in Malignant Melanoma.
Pathol. Oncol. Res. 28, 1-12, 2022.

doi DEA WoS Scopus

Journal metrics:

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q3 Oncology

Q2 Pathology and Forensic Medicine

10.

Szász, I., Koroknai, V., Vízkeleti, L., Balázs, M.: BRAF-inhibitor-kezelést követően kialakult rezisztencia molekuláris háttere BRAFV600E mutáns melanóma-sejtvonalakban.
Magyar Onkol. 65 (2), 149-156, 2021.

DEA Scopus

Journal metrics:

Q4 Medicine (miscellaneous)

Q4 Oncology

11.

Szász, I., Koroknai, V., Patel, V., Hajdú, T., Kiss, T., Ádány, R., Balázs, M.: Cell Proliferation Is Strongly Associated with the Treatment Conditions of an ER Stress Inducer New Anti-Melanoma Drug in Melanoma Cell Lines.
Biomedicines. 9 (2), 1-18, 2021.

doi DEA Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

12.

Patel, V., Szász, I., Koroknai, V., Kiss, T., Balázs, M.: Molecular Alterations Associated with Acquired Drug Resistance during Combined Treatment with Encorafenib and Binimetinib in Melanoma Cell Lines.
Cancers (Basel). 13 (23), 1-22, 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research

Q1 Oncology

13.

Kiss, T., Jámbor, K., Koroknai, V., Szász, I., Bárdos, H., Mokánszki, A., Ádány, R., Balázs, M.: Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma Cells.
Pathol. Oncol. Res. 27, 1-10, 2021.

doi DEA WoS Scopus

Journal metrics:

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q3 Oncology

Q2 Pathology and Forensic Medicine

14.

Koroknai, V., Szász, I., Hernandez, V. H., Fernandez, J. N., Cuenin, C., Herceg, Z., Vízkeleti, L., Ádány, R., Ecsedi, S., Balázs, M.: DNA hypermethylation is associated with invasive phenotype of malignant melanoma.
Exp. Dermatol. 29 (1), 39-50, 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q1 Dermatology

Q2 Molecular Biology

15.

Koroknai, V., Patel, V., Szász, I., Ádány, R., Balázs, M.: Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids.
Pathol. Oncol. Res. 26 (4), 2557-2566, 2020.

doi DEA WoS Scopus

Journal metrics:

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q3 Oncology

Q2 Pathology and Forensic Medicine

16.

Ádány, R., Pikó, P., Fiatal, S., Kósa, Z., Sándor, J., Bíró, É., Kósa, K., Paragh, G., Bácsné Bába, É., Veres-Balajti, I., Bíró, K., Varga, O., Balázs, M.: Prevalence of Insulin Resistance in the Hungarian General and Roma Populations as Defined by Using Data Generated in a Complex Health (Interview and Examination) Survey.
Int. J. Environ. Res. Public Health. 17 (4833), 1-22, 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Health, Toxicology and Mutagenesis

Q2 Pollution

Q2 Public Health, Environmental and Occupational Health

17.

Szász, I., Koroknai, V., Kiss, T., Vízkeleti, L., Ádány, R., Balázs, M.: Molecular alterations associated with acquired resistance to BRAFV600E targeted therapy in melanoma cells.
Melanoma Res. 29 (4), 390-400, 2019.

doi DEA

Journal metrics:

Q3 Cancer Research

Q1 Dermatology

Q2 Oncology

18.

Balázs, M., Koroknai, V., Szász, I., Ecsedi, S.: Detection of CCND1 Locus Amplification by Fluorescence In Situ Hybridization.
In: The Retinoblastoma Protein. Ed.: Pedro G. Santiago-Cardona, Springer Science+Business Media, New York, NY, 85-100, 2018. ISBN: 9781493975648

doi DEA

19.

Vízkeleti, L., Kiss, T., Koroknai, V., Ecsedi, S., Papp, O., Szász, I., Ádány, R., Balázs, M.: Altered integrin expression patterns revealed by microarray in human cutaneous melanoma.
Melanoma Res. 27 (3), 180-188, 2017.

DEA

Journal metrics:

Q2 Cancer Research

Q1 Dermatology

Q2 Oncology

20.

Koroknai, V., Ecsedi, S., Vízkeleti, L., Kiss, T., Szász, I., Lukács, A., Papp, O., Ádány, R., Balázs, M.: Genomic profiling of invasive melanoma cell lines by array comparative genomic hybridization.
Melanoma Res. 2, 100-107, 2016.

doi DEA

Journal metrics:

Q2 Cancer Research

Q1 Dermatology

Q2 Oncology

21.

Balázs, M., Vízkeleti, L., Ecsedi, S., Ádány, R., Rásó, E., Hegedűs, B., Ladányi, A., Tóvári, J., Tímár, J.: Hazai melanomakutatások: reményt keltő eredmények egy korábban reménytelen daganatban.
Magyar Onkol. 59, 275-281, 2015.

DEA

Journal metrics:

Q3 Medicine (miscellaneous)

Q4 Oncology

22.

Kiss, T., Ecsedi, S., Vízkeleti, L., Koroknai, V., Emri, G., Kovács, N., Ádány, R., Balázs, M.: The role of osteopontin expression in melanoma progression.
Tumor Biol. 36 (10), 7841-7847, 2015.

doi DEA

Journal metrics:

Q2 Cancer Research

Q1 Medicine (miscellaneous)

23.

Töröcsik, D., Bárdos, H., Hatalyák, Z., Dezső, B., Losonczy, G., Paragh, L., Péter, Z., Balázs, M., Remenyik, É., Ádány, R.: Detection of factor XIII-A is a valuable tool for distinguishing dendritic cells and tissue macrophages in granuloma annulare and necrobiosis lipoidica.
J. Eur. Acad. Dermatol. Venereol. 28 (8), 1087-1096, 2014.

doi DEA

Journal metrics:

D1 Dermatology

Q1 Infectious Diseases

24.

Ecsedi, S., Hernandez, V. H., Lima, S. C., Vízkeleti, L., Tóth, R., Lázár, V., Koroknai, V., Kiss, T., Emri, G., Herceg, Z., Ádány, R., Balázs, M.: DNA methylation characteristics of primary melanomas with distinct biological behaviour.
PloS One. 9 (5), e96612, 2014.

doi DEA

Journal metrics:

D1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Medicine (miscellaneous)

25.

Mezey, G., Treszl, A., Schally, A. V., Block, N. L., Vízkeleti, L., Juhász, A., Klekner, Á., Nagy, J., Balázs, M., Halmos, G., Bognár, L.: Prognosis in human glioblastoma based on expression of ligand growth hormone-releasing hormone, pituitary-type growth hormone-releasing hormone receptor, its splicing variant receptors, EGF receptor and PTEN genes.
J. Cancer Res. Clin. Oncol. 140 (10), 1641-1649, 2014.

doi DEA

Journal metrics:

Q2 Cancer Research

Q1 Medicine (miscellaneous)

Q2 Oncology

Publication list